359 related articles for article (PubMed ID: 17588815)
1. Translational aspects of sphingolipid metabolism.
Zeidan YH; Hannun YA
Trends Mol Med; 2007 Aug; 13(8):327-36. PubMed ID: 17588815
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids in cancer: regulation of pathogenesis and therapy.
Ogretmen B
FEBS Lett; 2006 Oct; 580(23):5467-76. PubMed ID: 16970943
[TBL] [Abstract][Full Text] [Related]
3. Molecular facets of sphingolipids: mediators of diseases.
Ozbayraktar FB; Ulgen KO
Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
[TBL] [Abstract][Full Text] [Related]
4. Sphingolipids and cell death.
Morales A; Lee H; Goñi FM; Kolesnick R; Fernandez-Checa JC
Apoptosis; 2007 May; 12(5):923-39. PubMed ID: 17294080
[TBL] [Abstract][Full Text] [Related]
5. Principles of bioactive lipid signalling: lessons from sphingolipids.
Hannun YA; Obeid LM
Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids: players in the pathology of metabolic disease.
Cowart LA
Trends Endocrinol Metab; 2009 Jan; 20(1):34-42. PubMed ID: 19008117
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid signalling in the cardiovascular system: good, bad or both?
Alewijnse AE; Peters SL
Eur J Pharmacol; 2008 May; 585(2-3):292-302. PubMed ID: 18420192
[TBL] [Abstract][Full Text] [Related]
8. Using genomic and lipidomic strategies to investigate sphingolipid function in the yeast heat-stress response.
Cowart LA; Hannun YA
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1166-9. PubMed ID: 16246073
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipids in infectious diseases.
Hanada K
Jpn J Infect Dis; 2005 Jun; 58(3):131-48. PubMed ID: 15973004
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development.
Duan RD; Nilsson A
Prog Lipid Res; 2009 Jan; 48(1):62-72. PubMed ID: 19027789
[TBL] [Abstract][Full Text] [Related]
11. Chemical tools to investigate sphingolipid metabolism and functions.
Delgado A; Casas J; Llebaria A; Abad JL; Fabriás G
ChemMedChem; 2007 May; 2(5):580-606. PubMed ID: 17252619
[TBL] [Abstract][Full Text] [Related]
12. Sphingolipids and insulin resistance: the five Ws.
Summers SA
Curr Opin Lipidol; 2010 Apr; 21(2):128-35. PubMed ID: 20216312
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid signalling and liver diseases.
Marí M; Fernández-Checa JC
Liver Int; 2007 May; 27(4):440-50. PubMed ID: 17403183
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid abnormalities in psychiatric disorders: a missing link in pathology?
Narayan S; Thomas EA
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1797-810. PubMed ID: 21196265
[TBL] [Abstract][Full Text] [Related]
15. Yeast sphingolipid metabolism: clues and connections.
Sims KJ; Spassieva SD; Voit EO; Obeid LM
Biochem Cell Biol; 2004 Feb; 82(1):45-61. PubMed ID: 15052327
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
Lim KG; Gray AI; Anthony NG; Mackay SP; Pyne S; Pyne NJ
Arch Toxicol; 2014 Dec; 88(12):2213-32. PubMed ID: 25344023
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism in Cryptococcus neoformans.
Shea JM; Henry JL; Del Poeta M
FEMS Yeast Res; 2006 Jun; 6(4):469-79. PubMed ID: 16696643
[TBL] [Abstract][Full Text] [Related]
18. The role of sphingolipids in drug metabolism and transport.
Kim YM; Park TS; Kim SG
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):319-31. PubMed ID: 23289866
[TBL] [Abstract][Full Text] [Related]
19. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.
Abou Daher A; El Jalkh T; Eid AA; Fornoni A; Marples B; Zeidan YH
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186855
[TBL] [Abstract][Full Text] [Related]
20. Epidermal sphingolipids: metabolism, function, and roles in skin disorders.
Holleran WM; Takagi Y; Uchida Y
FEBS Lett; 2006 Oct; 580(23):5456-66. PubMed ID: 16962101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
